Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Drug Resistant Epilepsy: early-phase trial registry
5 of 7 indexed Drug Resistant Epilepsy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Drug Resistant Epilepsy: 7 US clinical trials tracked, 5 recruiting.
Drug Resistant Epilepsy is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Michael A. Gelfand, MD, PhD, running 1 of these trials.
Enrollment posture brief
Registry condition drug-resistant-epilepsy
OPEN 5 | RECR 71% | LATE 0 | EARLY 2 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)
Drug Resistant Epilepsy lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Drug Resistant Epilepsy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Drug Resistant Epilepsy is recruiting above its size-band peers.
5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Drug Resistant Epilepsy trials is spread across many organizations.
Michael A. Gelfand, MD, PhD accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Drug Resistant Epilepsy trials plan to enrol fewer than 100 people.
Median target enrolment is 10 among the 7 trials that report a genuine target (sentinel values excluded). 6 of those (85.7%) plan for fewer than 100 participants.
-
Drug Resistant Epilepsy research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Goals for Epilepsy Clinic Visits Trial
University of Michigan
NCT05928598
Infrared Photobiomodulation in Humans With Epilepsy
Beth Israel Deaconess Medical Center
NCT07145489
Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial
Brigham and Women's Hospital
NCT03868293
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Madeline Fields
NCT05019885
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
NaviFUS Corporation
NCT06388707
Electrophysiologic Studies of Cognition in Epilepsy Patients
Icahn School of Medicine at Mount Sinai
NCT05769634
Novel Helmet Design in Patients With Seizures
Michael A. Gelfand, MD, PhD
NCT03443388
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Drug Resistant Epilepsy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Drug Resistant Epilepsy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Drug Resistant Epilepsy page
7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Drug Resistant Epilepsy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Michael A. Gelfand, MD, PhD sponsors the most Drug Resistant Epilepsy trials on record, review their full trial history before evaluating a specific study. See Michael A. Gelfand, MD, PhD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Drug Resistant Epilepsy condition card totals 7 registered trials; most-linked intervention Hövding inflatable helmet; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.